ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma
Authors
Keywords
TCR signaling, ITK, Therapeutic target, PTCL, AITL
Journal
Cancer Cell International
Volume 19, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-14
DOI
10.1186/s12935-019-0754-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of T-cell receptor signalling pathway components in extranodal NK/T-cell lymphoma
- (2018) Tomoko Miyata-Takata et al. HISTOPATHOLOGY
- NF-κB inducing kinase (NIK) is an essential post-transcriptional regulator of T-cell activation affecting F-actin dynamics and TCR signaling
- (2018) Sonja M. Lacher et al. JOURNAL OF AUTOIMMUNITY
- Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis
- (2018) Brittelle E. Kessler et al. ONCOGENE
- Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis
- (2018) Tiantao Gao et al. CANCER LETTERS
- FAK inhibitors in Cancer, a patent review
- (2017) Peng-Cheng Lv et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin
- (2017) Maria Pamela Dobay et al. HAEMATOLOGICA
- Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma
- (2017) M Fujisawa et al. LEUKEMIA
- Loss of RhoA promotes skin tumor formation and invasion by upregulation of RhoB
- (2017) A García-Mariscal et al. ONCOGENE
- Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin
- (2017) Maria Pamela Dobay et al. HAEMATOLOGICA
- Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas
- (2016) D. Vallois et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy
- (2016) Tianjiao Wang et al. CLINICAL CANCER RESEARCH
- The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma
- (2016) T Muramatsu et al. ONCOGENE
- Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter
- (2015) John C. Ashton CANCER RESEARCH
- IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
- (2015) C. C. Carson et al. CLINICAL CANCER RESEARCH
- Targeting BAG-1: A novel strategy to increase drug efficacy in acute myeloid leukemia
- (2015) Sanja Aveic et al. EXPERIMENTAL HEMATOLOGY
- Multistep tumorigenesis in peripheral T cell lymphoma
- (2015) Mamiko Sakata-Yanagimoto INTERNATIONAL JOURNAL OF HEMATOLOGY
- Targeting Interleukin-2-inducible T-cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694
- (2015) Yiming Zhong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recurrent activating mutations of CD28 in peripheral T-cell lymphomas
- (2015) J Rohr et al. LEUKEMIA
- Intracellular TCR-signaling Pathway
- (2014) Claudio Agostinelli et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Peripheral T cell lymphoma in Asia
- (2014) Sanghui Park et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma
- (2014) Hae Yong Yoo et al. NATURE GENETICS
- Somatic RHOA mutation in angioimmunoblastic T cell lymphoma
- (2014) Mamiko Sakata-Yanagimoto et al. NATURE GENETICS
- Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
- (2014) Teresa Palomero et al. NATURE GENETICS
- Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia
- (2013) R. M. A. Linger et al. BLOOD
- Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
- (2013) J. A. Dubovsky et al. BLOOD
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs
- (2012) Christopher T. Saunders et al. BIOINFORMATICS
- Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters
- (2012) F. Lemonnier et al. BLOOD
- IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma
- (2012) R. A. Cairns et al. BLOOD
- NF- B, the first quarter-century: remarkable progress and outstanding questions
- (2012) M. S. Hayden et al. GENES & DEVELOPMENT
- Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01
- (2012) Francesco d'Amore et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinicopathologic Characteristics of Angioimmunoblastic T-Cell Lymphoma: Analysis of the International Peripheral T-Cell Lymphoma Project
- (2012) Massimo Federico et al. JOURNAL OF CLINICAL ONCOLOGY
- Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data
- (2011) Valentina Boeva et al. BIOINFORMATICS
- TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
- (2011) Cyril Quivoron et al. CANCER CELL
- Tec family kinases Itk and Rlk / Txk in T lymphocytes: cross-regulation of cytokine production and T-cell fates
- (2011) Julio Gomez-Rodriguez et al. FEBS Journal
- Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group
- (2010) N. Schmitz et al. BLOOD
- The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma
- (2010) Konstanze Pechloff et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T-Cell Signaling Regulated by the Tec Family Kinase, Itk
- (2010) A. H. Andreotti et al. Cold Spring Harbor Perspectives in Biology
- T Cell Activation
- (2009) Jennifer E. Smith-Garvin et al. Annual Review of Immunology
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- ITK Inhibitors in Inflammation and Immune-Mediated Disorders
- (2009) Nisebita Sahu et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Girls homozygous for an IL-2–inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation
- (2009) Kirsten Huck et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines
- (2009) R A Wilcox et al. LEUKEMIA
- Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials
- (2008) N. Mourad et al. BLOOD
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
- (2008) JOURNAL OF CLINICAL ONCOLOGY
- Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas
- (2008) A L Feldman et al. LEUKEMIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started